9 completed, 5 terminated. 14 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 9, Terminated 5 |
Follow torcetrapib: new trials by email Literature Review of torcetrapib trials Research Report on torcetrapib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. torcetrapib/atorvastatin, ezetimibe/simvastatin - Hyperlipidemia, Dyslipidemia | Phase 3 | Terminated | Pfizer | 1784 | 2006-01-01 | 2007-12-10 |
| A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. torcetrapib/atorvastatin, simvastatin - Hyperlipidemia, Dyslipidemia | Phase 3 | Completed | Pfizer | 640 | 2006-01-01 | 2007-11-21 |
| A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). torcetrapib/atorvastatin, simvastatin - Hyperlipidemia, Dyslipidemia | Phase 3 | Terminated | Pfizer | 640 | 2006-01-01 | 2012-02-17 |
| Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia torcetrapib/atorvastatin, atorvastatin - Hypercholesterolemia, Familial, Hyperlipidemia | Phase 3 | Completed | Pfizer | 400 | 2005-03-01 | 2007-10-30 |
| Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate Torcetrapib/Atorvastatin, Fenofibrate - Hyperlipidemia | Phase 3 | Completed | Pfizer | 128 | 2005-03-01 | 2007-10-31 |
| Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. torcetrapib/atorvastatin, atorvastatin, fenofibrate - Hyperlipoproteinemia Type III | Phase 3 | Terminated | Pfizer | 41 | 2005-03-01 | 2012-02-17 |
| Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder Torcetrapib/atorvastatin - Hypercholesterolemia, Familial | Phase 3 | Completed | Pfizer | 30 | 2005-03-01 | 2007-11-07 |
| A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides torcetrapib/atorvastatin, atorvastatin - Hypertriglyceridemia, Hyperlipoproteinemia Type IV | Phase 3 | Completed | Pfizer | 160 | 2005-02-01 | 2007-11-16 |
| Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone. torcetrapib/atorvastatin, atorvastatin - Hyperlipidemia | Phase 3 | Completed | Pfizer | 900 | 2004-11-01 | 2007-11-16 |
| A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease torcetrapib/atorvastatin, atorvastatin - Coronary Disease, Diabetes Mellitus | Phase 3 | Terminated | Pfizer | 15067 | 2004-07-01 | 2012-02-03 |
| A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol torcetrapib/atorvastatin, atorvastatin, placebo - Hyperlipidemia | Phase 3 | Completed | Pfizer | 3800 | 2004-07-01 | 2012-02-17 |
| Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. torcetrapib/atorvastatin, atorvastatin - Hypercholesterolemia, Familial, Hyperlipidemia | Phase 3 | Completed | Pfizer | 800 | 2003-12-01 | 2015-04-22 |
| Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. torcetrapib/atorvastatin, atorvastatin - Mixed Hyperlipidemia | Phase 3 | Terminated | Pfizer | 755 | 2003-11-01 | 2012-02-17 |
| A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease torcetrapib/atorvastatin, atorvastatin - Coronary Disease, Coronary Arteriosclerosis | Phase 3 | Completed | Pfizer | 1100 | 2003-10-01 | 2007-12-10 |
Hyperlipidemias (9) · Hyperlipoproteinemia Type II (4) · Dyslipidemias (3) · Coronary Disease (2) · Hypercholesterolemia (2) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Hyperlipoproteinemia Type III (1) · Hyperlipoproteinemia Type IV (1) · Hypertriglyceridemia (1)
Pfizer (14)
United States (13) · Canada (9) · France (4) · Netherlands (4) · South Africa (3) · Sweden (3) · Australia (2) · Belgium (2) · Czechia (2) · Finland (2) · Norway (2) · Spain (2) · United Kingdom (2) · Denmark (1) · Germany (1)
PMID 19029469, PMID 17407645, PMID 20228610, PMID 20645885, PMID 21613319, PMID 17387129, PMID 17387131, PMID 17630038, PMID 17984165, PMID 19029466, PMID 21804130, PMID 28431663, PMID 28974520, PMID 29103916, PMID 37565307